Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome.

Saved in:
Bibliographic Details
Title: Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome.
Authors: Galili N; Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY 10032, USA. ng2368@columbia.edu, Tamayo P, Botvinnik OB, Mesirov JP, Brooks MR, Brown G, Raza A
Source: Journal of hematology & oncology [J Hematol Oncol] 2012 May 06; Vol. 5, pp. 20. Date of Electronic Publication: 2012 May 06.
Publication Type: Journal Article
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-8722
DOI:10.1186/1756-8722-5-20